Background Oral anticoagulation (OAC) effectively reduces stroke risk in patients with atrial fibrillation (AF), but its use ...

Background Smoking is a significant risk factor for neurological disorders, yet its global impact on these conditions remains underexplored. Methods Using Global Burden of Diseases 2021 data, we ...

Background Benign multiple sclerosis (MS), characterised by minimal disability despite long disease duration, remains poorly understood in terms of its determinants and prognostic implications. While ...

Background Following acute stroke, long-term secondary prevention is typically the responsibility of primary care. However, discharge summaries communicating with GPs are normally completed by junior ...

Tremor is one of the clinical manifestations of dystonia; however, there are no specific therapeutic trials evaluating the efficacy of treatments for dystonic tremor (DT), tremor associated with ...

Neuroimage Nord, Klinik und Poliklinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Correspondence to: G Thomalla Klinik und Poliklinik für Neurologie, Universitätsklinikum ...

Correspondence to Hanneke Frederica Maria Rhodius-Meester, Alzheimer Center, VU University Medical Center, Amsterdam 1007 MB, The Netherlands; h.rhodius{at}vumc.nl Patients with dementia have a ...

Background Cerebellar ataxias are the result of diverse disease processes that can be genetic or acquired. Establishing a diagnosis requires a methodical approach with expert clinical evaluation and ...

1 School of Health Professions and Rehabilitation Sciences, University of Southampton, Southampton General Hospital, Southampton, UK 2 Faculty of Health and Social Care, London South Bank University, ...

OBJECTIVES The detection of the protein 14–3–3 in the CSF has been shown to be a reliable and sensitive marker for sporadic Creutzfeldt-Jakob disease (CJD). Other brain-specific proteins such as ...

Correspondence to Dr William Stewart, Department of Neuropathology, NHS Greater Glasgow and Clyde, Glasgow G51 4TF, UK; william.stewart{at}glasgow.ac.uk Introduction There is growing recognition of an ...

1 MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, London, UK 2 Lysholm Department of Neuroradiology, National Hospital of Neurology and Neurosurgery, Institute of ...